U.S. Venture Partners
Menlo Park, Californiausvp.com
Overview
U.S. Venture Partners is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cagent Vascular | May 2026 | Series D | Lead |
| Nervonik | Apr 2026 | Series B | Co-investor |
| Route 92 Medical | Apr 2026 | Series F Extension | Co-investor |
| Slang AI | Feb 2026 | Series B | Lead |
| Adaptive6 | Jan 2026 | Series A | Lead |
Key People
Jacques Benkoski
General Partner
Jonathan Root
General Partner
Matt Garratt
General Partner
Rick Lewis
General Partner
Steve Krausz
General Partner
Irwin Federman
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
